FTC urged not to corner local drug makers

Published: 2007-09-03 06:58:00

Updated: 2007-09-03 06:58:00

Fair Trade Commission (FTC)'s recent probe into 200 local drug companies for their illegal business practice, including rebate-offerings to area hospitals, could hit some damage to the pharmaceutical industry in an era of the Korea-U.S. FTA, said the Korea Pharmaceutical Manufacturers Association...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK